SCHOTT Expands Portfolio of Ready-to-use Pharma Vials as Adoption Increases

January 17, 2017
SCHOTT AG, Germany

Sponsored Content

SCHOTT has expanded its portfolio of ready-to-use pharma containers to meet growing market demand and allows pharma companies to trim costs while boosting efficiency, leading to higher profits.

SCHOTT has expanded its portfolio of ready-to-use pharma containers to meet growing market demand from drug manufacturers. The latest nest format will be able to hold 20R, 25R, or 30R ISO vials when it’s released in 2017, and will add to the existing 2R to 15R formats. The adaptiQ® concept permits pharma firms to fill different container formats on one production line while minimizing burdensome changeover times in between. SCHOTT developed adaptiQ® to be compatible with the industry’s filling and finishing equipment, and collectively, industry leaders such as Bausch & Stroebel, Bosch Packaging Technology, Groninger, Optima, and Vanrx have tested and verified adaptiQ® on a large number of machine types.

This ready-to-use packaging solution enables pharma companies to react quicker to new industry trends without building specific manufacturing capabilities. The vials are nested securely, protecting them from scratches caused by vial-to-vial and vial-to-machine contact, and reducing breakage and contamination. As they are already sterilized, pharma companies can load them directly onto filling lines without expensive and time-consuming washing, sterilizing, and depyrogenation. The entire portfolio of ready-to-use vials allows pharma companies to trim costs while boosting efficiency, leading to higher profits.

 

Company name:  SCHOTT AG, Germany

Website: http://www.schott.com/

E-mail: chtistina.rettig@schott.com

Name of product: SCHOTT adapti®Q